Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantNOVARTIS (SINGAPORE) PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
POWDER, FOR SUSPENSION
ORAL
Medical Information
J01FA10
azithromycin
Manufacturer Information
NOVARTIS (SINGAPORE) PTE LTD
Sandoz S.R.L.
Active Ingredients
Documents
Package Inserts
1.4.3_PI_Binozyt POS 200mg5ml_Proposed MAY 2021.pdf
Approved: May 20, 2021